With a single blood test (ExoPro™), we can both determine and rule out presence of significant prostate cancer. The method is easy to adapt to existing laboratory automation systems. The current tests on the market can only show the potential risk of cancer and require further testing or biopsy to determine a final diagnosis. It is our expectation that the ExoPro™ shall require no further testing or biopsy.
Detection and diagnosis with one test
The statistics that drive our scientists
Waiting for cancer diagnosis, regardless of outcome is very stressful. Standard methods include multiple steps that are both invasive, sometimes painful and require waiting. ExoPro™ is a single step process that only takes a few hours. The test will accurately tell presence of significant prostate cancer.
Huge amounts to be saved